These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
193 related articles for article (PubMed ID: 28178672)
21. MicroRNA-98 sensitizes cisplatin-resistant human lung adenocarcinoma cells by up-regulation of HMGA2. Xiang Q; Tang H; Yu J; Yin J; Yang X; Lei X Pharmazie; 2013 Apr; 68(4):274-81. PubMed ID: 23700794 [TBL] [Abstract][Full Text] [Related]
22. Comparative analysis of microRNA and mRNA expression profiles in cells and exosomes under toluene exposure. Lim JH; Song MK; Cho Y; Kim W; Han SO; Ryu JC Toxicol In Vitro; 2017 Jun; 41():92-101. PubMed ID: 28245982 [TBL] [Abstract][Full Text] [Related]
23. Plasma exosome microRNAs are indicative of breast cancer. Hannafon BN; Trigoso YD; Calloway CL; Zhao YD; Lum DH; Welm AL; Zhao ZJ; Blick KE; Dooley WC; Ding WQ Breast Cancer Res; 2016 Sep; 18(1):90. PubMed ID: 27608715 [TBL] [Abstract][Full Text] [Related]
24. Integrated microRNA and gene expression profiling reveals the crucial miRNAs in curcumin anti-lung cancer cell invasion. Zhan JW; Jiao DM; Wang Y; Song J; Wu JH; Wu LJ; Chen QY; Ma SL Thorac Cancer; 2017 Sep; 8(5):461-470. PubMed ID: 28660665 [TBL] [Abstract][Full Text] [Related]
26. miR-27b-3p suppresses cell proliferation through targeting receptor tyrosine kinase like orphan receptor 1 in gastric cancer. Tao J; Zhi X; Zhang X; Fu M; Huang H; Fan Y; Guan W; Zou C J Exp Clin Cancer Res; 2015 Nov; 34():139. PubMed ID: 26576539 [TBL] [Abstract][Full Text] [Related]
28. MicroRNA-218 regulates cisplatin (DPP) chemosensitivity in non-small cell lung cancer by targeting RUNX2. Xie J; Yu F; Li D; Zhu X; Zhang X; Lv Z Tumour Biol; 2016 Jan; 37(1):1197-204. PubMed ID: 26282001 [TBL] [Abstract][Full Text] [Related]
29. Lung adenocarcinoma cell-derived exosomal miR-21 facilitates osteoclastogenesis. Xu Z; Liu X; Wang H; Li J; Dai L; Li J; Dong C Gene; 2018 Aug; 666():116-122. PubMed ID: 29730429 [TBL] [Abstract][Full Text] [Related]
30. Identification of carcinogenic potential-associated molecular mechanisms in CD133(+) A549 cells based on microRNA profiles. Chen QY; Jiao DM; Zhu Y; Hu H; Wang J; Tang X; Chen J; Yan L Tumour Biol; 2016 Jan; 37(1):521-30. PubMed ID: 26227219 [TBL] [Abstract][Full Text] [Related]
31. MiR-199a-3p enhances breast cancer cell sensitivity to cisplatin by downregulating TFAM (TFAM). Fan X; Zhou S; Zheng M; Deng X; Yi Y; Huang T Biomed Pharmacother; 2017 Apr; 88():507-514. PubMed ID: 28126676 [TBL] [Abstract][Full Text] [Related]
32. MiR-223 promotes the cisplatin resistance of human gastric cancer cells via regulating cell cycle by targeting FBXW7. Zhou X; Jin W; Jia H; Yan J; Zhang G J Exp Clin Cancer Res; 2015 Mar; 34(1):28. PubMed ID: 25888377 [TBL] [Abstract][Full Text] [Related]
33. Concordant dysregulation of miR-5p and miR-3p arms of the same precursor microRNA may be a mechanism in inducing cell proliferation and tumorigenesis: a lung cancer study. Mitra R; Lin CC; Eischen CM; Bandyopadhyay S; Zhao Z RNA; 2015 Jun; 21(6):1055-65. PubMed ID: 25852169 [TBL] [Abstract][Full Text] [Related]
35. Exosomes secreted from human colorectal cancer cell lines contain mRNAs, microRNAs and natural antisense RNAs, that can transfer into the human hepatoma HepG2 and lung cancer A549 cell lines. Chiba M; Kimura M; Asari S Oncol Rep; 2012 Nov; 28(5):1551-8. PubMed ID: 22895844 [TBL] [Abstract][Full Text] [Related]
36. microRNA-1236-3p Regulates DDP Resistance in Lung Cancer Cells. Wang Z; Liu L; Guo X; Guo C; Wang W Open Med (Wars); 2018; 14():41-51. PubMed ID: 30805558 [TBL] [Abstract][Full Text] [Related]
37. MiR-31 regulates the cisplatin resistance by targeting Src in gallbladder cancer. Li M; Chen W; Zhang H; Zhang Y; Ke F; Wu X; Zhang Y; Weng M; Liu Y; Gong W Oncotarget; 2016 Dec; 7(50):83060-83070. PubMed ID: 27825112 [TBL] [Abstract][Full Text] [Related]
38. MicroRNA-451 sensitizes lung cancer cells to cisplatin through regulation of Mcl-1. Cheng D; Xu Y; Sun C; He Z Mol Cell Biochem; 2016 Dec; 423(1-2):85-91. PubMed ID: 27686452 [TBL] [Abstract][Full Text] [Related]
39. Exosomes from bulk and stem cells from human prostate cancer have a differential microRNA content that contributes cooperatively over local and pre-metastatic niche. Sánchez CA; Andahur EI; Valenzuela R; Castellón EA; Fullá JA; Ramos CG; Triviño JC Oncotarget; 2016 Jan; 7(4):3993-4008. PubMed ID: 26675257 [TBL] [Abstract][Full Text] [Related]
40. Primary tumor microRNA signature predicts recurrence and survival in patients with locally advanced esophageal adenocarcinoma. Matsui D; Zaidi AH; Martin SA; Omstead AN; Kosovec JE; Huleihel L; Saldin LT; DiCarlo C; Silverman JF; Hoppo T; Finley GG; Badylak SF; Kelly RJ; Jobe BA Oncotarget; 2016 Dec; 7(49):81281-81291. PubMed ID: 27793030 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]